Senores Pharmaceuticals Limited (NSE:SENORES)

Market Cap	41.41B +71.9%
Revenue (ttm)	5.53B +43.2%
Net Income	1.02B +79.3%
EPS	22.43 +40.3%
Shares Out	46.05M
PE Ratio	40.09
Forward PE	31.19
Dividend	n/a
Ex-Dividend Date	n/a

Volume	149,547
Average Volume	306,668
Open	907.85
Previous Close	903.50
Day's Range	893.20 - 918.00
52-Week Range	475.00 - 947.70
Beta	n/a
RSI	61.09
Earnings Date	May 30, 2026

About Senores Pharmaceuticals

Senores Pharmaceuticals Limited develops, manufactures, sells, and trades in pharmaceutical and allied products in India, the United States, the United Kingdom, Canada, and internationally. It offers pharmaceutical solutions, such as analgesic/antipyretic, anesthetics and allied products, antibacterial/antibiotic, antiviral, antifungal, antioxidants, antineoplastic, blood line, cardiovascular, neurology, antacid, and vitamin and mineral preparation solutions; and analgesic/anti-inflammatory/antipyretic, anti-diabetic, antimalarial, neutral supp...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 2017
• Employees: 194
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: SENORES

Financial Performance

In fiscal year 2025, Senores Pharmaceuticals's revenue was 3.98 billion, an increase of 85.65% compared to the previous year's 2.15 billion. Earnings were 585.60 million, an increase of 86.20%.